Article Sidebar

PDF (Tiếng Việt)
Published: 2023-02-28
Abstract Views: 363
Views PDF (Tiếng Việt): 367
DOI: https://doi.org/10.52852/tcncyh.v163i2.1211
Issue
Vol. 163 No. 2 (2023)
Section
Các bài báo
How to Cite
Nam, H. M., Hoàng, T. T., Hạnh, H. T. H., Khương, C. B., & Lan, N. T. P. (2023). 30. Willingness to pay for the Covid-19 vaccine available in Vietnam and some factors related. Journal of Medical Research, 163(2), 265-274. https://doi.org/10.52852/tcncyh.v163i2.1211

30. Willingness to pay for the Covid-19 vaccine available in Vietnam and some factors related

Hoang Minh Nam, Tran The Hoang, Hoa Thi Hong Hanh, Cao Ba Khuong, Nguyen Thi Phuong Lan

Main Article Content

Abstract

Vaccines against COVID-19 are made with different prices, effectiveness and side effects. This study aims to determine the willingness to pay for a COVID-19 vaccine in Vietnam during the fourth wave of COVID-19. The online study included 2093 unvaccinated subjects aged 18 years and over. Multivariate logistic regression was used to identify factors related to willingness to pay for vaccination. Research results show that the proportion of subjects had willingness to pay for Astra Zeneca vaccine; Sputnik V; Pfizer-BioNTech was 69.6% respectively; 70.0%; 67.8%. There was a relationship between occupational factors, household income, history of allergies, job change due to COVID-19 and willingness to pay to use Astra Zeneca vaccine; between occupation, household economy, job change and willingness to pay for Sputnik V vaccine and between occupation, household economics, chronic illness, history of allergies, job change, risk of infection with HIV willingness to pay to use the Pfizer-BioNTech vaccine (p < 0.05).

Article Details

Keywords

Willingness to pay, Vaccines, COVID-19, Related factors

References

1. Le T-AT, Vodden K, Wu J, Atiwesh G. Policy Responses to the COVID-19 Pandemic in Vietnam. Int J Environ Res Public Health. 2021; 18(2): 559. doi: 10.3390/ijerph18020559.
2. Bartsch SM, O’Shea KJ, Ferguson MC, et al. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention. Am J Prev Med. Oct 2020; 59(4): 493-503. doi: 10.1016/j.amepre.2020.06.011.
3. Leshem E, Lopman BA. Population immunity and vaccine protection against infection. The Lancet. 2021; 397(10286): 1685-1687. doi: 10.1016/S0140-6736(21)00870-9.
4. Tran VD, Pak TV, Gribkova EI, et al. Determinants of COVID-19 vaccine acceptance in a high infection-rate country: a cross-sectional study in Russia. Pharm Pract (Granada). Jan-Mar 2021; 19(1): 2276. doi: 10.18549/PharmPract.2021.1.2276.
5. Kaplan RM, Milstein A. Influence of a COVID-19 vaccine’s effectiveness and safety profile on vaccination acceptance. Proc Natl Acad Sci U S A. Mar 9 2021; 118(10). doi: 10.1073/pnas.2021726118.
6. Liu R, Zhang Y, Nicholas S, Leng A, Maitland E, Wang J. COVID-19 Vaccination Willingness among Chinese Adults under the Free Vaccination Policy. Vaccines (Basel). Mar 21 2021; 9(3). doi: 10.3390/vaccines9030292.
7. Health Mo. Decision Approving Conditional Application for Urgent Request in COVID-19 Epidemic Prevention and Control. 2021.
8. Vo NX, Huyen Nguyen TT, Van Nguyen P, Tran QV, Vo TQ. Using Contingent Valuation Method to Estimate Adults’ Willingness to Pay for a Future Coronavirus 2019 Vaccination. Value Health Reg Issues. May 2021; 24:240-246. doi: 10.1016/j.vhri.2021.01.002.
9. Lazarus JV, Ratzan SC, Palayew A, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nature Medicine. 2021/02/01 2021; 27(2): 225-228. doi: 10.1038/s41591-020-1124-9.
10. Qin W, Wang E, Ni Z. Chinese consumers’ willingness to get a COVID-19 vaccine and willingness to pay for it. PLOS ONE. 2021; 16(5): e0250112. doi: 10.1371/journal.pone.0250112.
11. Olive JK, Hotez PJ, Damania A, Nolan MS. The state of the antivaccine movement in the United States: A focused examination of nonmedical exemptions in states and counties. PLOS Medicine. 2018; 15(6): e1002578. doi: 10.1371/journal.pmed.1002578.
12. The Lancet C, amp, Adolescent H. Vaccine hesitancy: a generation at risk. The Lancet Child & Adolescent Health. 2019; 3(5): 281. doi: 10.1016/S2352-4642(19)30092-6.
13. Hotez PJ, Cooney RE, Benjamin RM, et al. Announcing the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA. The Lancet. 2021; 397(10280): 1165-1167. doi: 10.1016/S0140-6736(21)00372-X.
14. Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. Sep 29 2020; 38(42): 6500-6507. doi: 10.1016/j.vaccine.2020.08.043.
15. Catma S, Varol S. Willingness to Pay for a Hypothetical COVID-19 Vaccine in the United States: A Contingent Valuation Approach. Vaccines. 2021; 9(4): 318.
16. Zhang KC, Fang Y, Cao H, et al. Behavioral Intention to Receive a COVID-19 Vaccination Among Chinese Factory Workers: Cross-sectional Online Survey. J Med Internet Res. Mar 9 2021;23(3):e24673. doi: 10.2196/24673.